Sphera Funds Management Ltd. Celldex Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

$380 Million
Q1 2025

A detailed history of Sphera Funds Management Ltd. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 507,829 shares of CLDX stock, worth $10 Million. This represents 2.43% of its overall portfolio holdings.

Number of Shares

507,829

Previous 474,103 7.11%

Holding current value

$10 Million

Previous $12 Million 23.06%

% of portfolio

2.43%

Previous 2.47%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$18.15 - $27.6 $612,126 - $930,837	33,726 Added 7.11%	507,829 $9.22 Million
Q4 2024 Feb 14, 2025	BUY	$23.31 - $32.4 $1.28 Million - $1.78 Million	55,000 Added 13.12%	474,103 $12 Million
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $3.52 Million - $4.89 Million	109,838 Added 35.52%	419,103 $14.2 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $1.06 Million - $1.37 Million	32,269 Added 11.65%	309,265 $11.4 Million
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $1.36 Million - $2.01 Million	-38,648 Reduced 12.24%	276,996 $11.6 Million
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $3.07 Million - $5.51 Million	135,644 Added 75.36%	315,644 $12.5 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $509,000 - $749,200	20,000 Added 12.5%	180,000 $4.95 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $4.85 Million - $6.12 Million	160,000 New	160,000 $5.43 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $4.61 Million - $6.56 Million	-166,766 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $1.3 Million - $2.05 Million	36,436 Added 27.96%	166,766 $6.44 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $3.77 Million - $7.3 Million	130,330 New	130,330 $7.04 Million
Q2 2021 Aug 17, 2021	SELL	$20.71 - $35.37 $4.56 Million - $7.79 Million	-220,320 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $6.1 Million - $11.3 Million	-376,878 Reduced 63.11%	220,320 $4.54 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $3.41 Million - $5.17 Million	227,198 Added 61.4%	597,198 $10.5 Million
Q3 2020 Nov 12, 2020	BUY	$9.65 - $15.19 $3.57 Million - $5.62 Million	370,000 New	370,000 $5.49 Million

Others Institutions Holding CLDX

# of Institutions

188

Shares Held

69.3M

Call Options Held

220K

Put Options Held

310K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $925M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Celldex Therapeutics, Inc. Transaction History